Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
SELLAS Life Sciences Group, Inc. (SLS) had Weighted-Average Shares Outstanding (Diluted) of 172.48M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-8.41M |
|
-- |
|
-- |
|
$9.25M |
|
$-9.25M |
|
$0.84M |
|
$-8.41M |
|
$-8.41M |
|
$-8.41M |
|
$-8.41M |
|
$-8.41M |
|
$-8.41M |
|
$-9.25M |
|
$-9.25M |
|
172.48M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
172.48M |
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$111.17M |
|
-- |
|
$3.01M |
|
$114.18M |
|
$6.46M |
|
-- |
|
$0.31M |
|
$6.76M |
|
$107.41M |
|
$105.50M |
|
$107.41M |
|
181.33M |
|
| Cash Flow Statement Financials | |
$-8.85M |
|
-- |
|
$44.15M |
|
$71.89M |
|
$107.20M |
|
$35.30M |
|
$0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.83% |
|
-7.97% |
|
-7.36% |
|
-7.83% |
|
$0.59 |
|
$-0.05 |
|
$-0.05 |
|